We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Virus-like particles (B) used to vaccinate mice against ebola are morphologically similar to the authentic Ebola virus (A).

Scientists have created a vaccine that has successfully immunised mice against the deadly Ebola virus, which causes haemorrhagic fever and kills up to 90 per cent of its victims.

The vaccine is made up of virus-like particles that are not infectious but are capable of triggering a strong response by the immune system.

The study, which is published in the Proceedings of the National Academy of Sciences, could pave the way to a vaccine that will protect humans from the virus.

Link to full BBC Online news story

Related topics